{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:46:34Z","timestamp":1792583194334,"version":"4.5.0"},"reference-count":189,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021801","name":"Prinses M\u00e1xima Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.modpat.2026.101051","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:39:32Z","timestamp":1788478772000},"page":"101051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Paragangliomas and Pheochromocytomas: Integrating Developmental Biology With Translational Technologies. A Narrative Review"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5784-2638","authenticated-orcid":false,"given":"Carolijn J.M.","family":"de Bresser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald R.","family":"de Krijger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.modpat.2026.101051_bib1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting","year":"2022","journal-title":"Endocr Rev"},{"key":"10.1016\/j.modpat.2026.101051_bib2","series-title":"Comparative Anatomy and Histology: A Mouse and Human Atlas","first-page":"211","article-title":"Endocrine system","author":"DuBray La Perle","year":"2012"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1196\/annals.1353.059","article-title":"Pathology of pheochromocytoma and extra-adrenal paraganglioma","volume":"1073","author":"Tischler","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2026.101051_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/jcm7090280","article-title":"The diagnosis and clinical significance of paragangliomas in unusual locations","volume":"7","author":"Asa","year":"2018","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/PAP.0000000000000365","article-title":"Advances in adrenal and extra-adrenal paraganglioma: practical synopsis for pathologists","volume":"30","author":"Juhlin","year":"2023","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/1066896917720750","article-title":"Functional ulnar nerve paraganglioma: first documented occurrence in the extremity with hitherto undescribed associated extensive glomus cell hyperplasia and tumorlet formation","volume":"26","author":"Chow","year":"2018","journal-title":"Int J Surg Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101051_bib8","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.modpat.2026.101051_bib9","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.annonc.2020.08.2099","article-title":"Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Fassnacht","year":"2020","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101051_bib10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/81551","article-title":"Mutations in SDHC cause autosomal dominant paraganglioma, type 3","volume":"26","author":"Niemann","year":"2000","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.modpat.2026.101051_bib11","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/cancers16050986","article-title":"The additional value of somatostatin receptor positron emission computed tomography ([68Ga]Ga-DOTATOC PET\/CT) compared with magnetic resonance imaging of the head and neck region in paraganglioma patients: a pilot study","volume":"16","author":"de Bresser","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.modpat.2026.101051_bib12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2967\/jnumed.118.211706","article-title":"Performance of 68Ga-DOTA\u2013conjugated somatostatin receptor\u2013targeting peptide PET in detection of pheochromocytoma and paraganglioma: a systematic review and metaanalysis","volume":"60","author":"Han","year":"2019","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.modpat.2026.101051_bib13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/0284185113496679","article-title":"Diagnostic role of gallium-68 DOTATOC and gallium-68 DOTATATE PET in patients with neuroendocrine tumors: a meta-analysis","volume":"55","author":"Yang","year":"2014","journal-title":"Acta radiol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40644-016-0084-2","article-title":"68Ga-DOTATATE and 18F-FDG PET\/CT in paraganglioma and pheochromocytoma: utility, patterns and heterogeneity","volume":"16","author":"Chang","year":"2016","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.modpat.2026.101051_bib15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.conb.2017.11.004","article-title":"Specification, plasticity and evolutionary origin of peripheral glial cells","volume":"47","author":"Kastriti","year":"2017","journal-title":"Curr Opin Neurobiol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1700360102","article-title":"Familial and bilateral tumours of the carotid body","volume":"36","author":"Chase","year":"1933","journal-title":"J Pathol Bacteriol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101051_bib17","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/jmedgenet-2017-105127","article-title":"Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD","volume":"55","author":"Andrews","year":"2018","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.modpat.2026.101051_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.185","article-title":"Consensus statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas","volume":"13","author":"Toledo","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib19","article-title":"Germline genetic variants in pheochromocytoma\/paraganglioma: single-center experience","volume":"3","author":"Lima","year":"2023","journal-title":"Endocr Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib20","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1530\/EJE-17-0523","article-title":"Diagnosis of endocrine disease: SDHx mutations: beyond pheochromocytomas and paragangliomas","volume":"178","author":"Mannelli","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma","volume":"69","author":"Astuti","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.modpat.2026.101051_bib22","first-page":"848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma","volume":"287","author":"Baysal","year":"2000","journal-title":"Science (1979)"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12105-022-01414-z","article-title":"Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: familial tumor syndromes","volume":"16","author":"Nos\u00e9","year":"2022","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.modpat.2026.101051_bib24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.semcdb.2022.02.017","article-title":"The transcriptional portraits of the neural crest at the individual cell level","volume":"138","author":"Erickson","year":"2023","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.modpat.2026.101051_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fnmol.2019.00006","article-title":"Schwann cell precursors generate the majority of chromaffin cells in Zuckerkandl organ and some sympathetic neurons in paraganglia","volume":"12","author":"Kastriti","year":"2019","journal-title":"Front Mol Neurosci"},{"issue":"6346","key":"10.1016\/j.modpat.2026.101051_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal3753","article-title":"Multipotent peripheral glial cells generate neuroendocrine cells of the adrenal medulla","volume":"357","author":"Furlan","year":"2017","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.modpat.2026.101051_bib27","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.cell.2009.07.049","article-title":"Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin","volume":"139","author":"Adameyko","year":"2009","journal-title":"Cell"},{"issue":"6192","key":"10.1016\/j.modpat.2026.101051_bib28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1126\/science.1253281","article-title":"Neurodevelopment. Parasympathetic neurons originate from nerve-associated peripheral glial progenitors","volume":"345","author":"Dyachuk","year":"2014","journal-title":"Science"},{"issue":"6192","key":"10.1016\/j.modpat.2026.101051_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.1253286","article-title":"Neurodevelopment. Parasympathetic ganglia derive from Schwann cell precursors","volume":"345","author":"Espinosa-Medina","year":"2014","journal-title":"Science"},{"issue":"Suppl 1","key":"10.1016\/j.modpat.2026.101051_bib30","doi-asserted-by":"crossref","first-page":"S308","DOI":"10.1016\/j.ydbio.2018.05.016","article-title":"Striking parallels between carotid body glomus cell and adrenal chromaffin cell development","volume":"444","author":"Hockman","year":"2018","journal-title":"Dev Biol"},{"issue":"45","key":"10.1016\/j.modpat.2026.101051_bib31","doi-asserted-by":"crossref","first-page":"11980","DOI":"10.1073\/pnas.1710308114","article-title":"Dual origin of enteric neurons in vagal Schwann cell precursors and the sympathetic neural crest","volume":"114","author":"Espinosa-Medina","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"27","key":"10.1016\/j.modpat.2026.101051_bib32","doi-asserted-by":"crossref","first-page":"9879","DOI":"10.1523\/JNEUROSCI.1239-15.2015","article-title":"Neuronal differentiation in Schwann cell lineage underlies postnatal neurogenesis in the enteric nervous system","volume":"35","author":"Uesaka","year":"2015","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.modpat.2026.101051_bib33","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41588-021-00818-x","article-title":"Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin","volume":"53","author":"Kameneva","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.modpat.2026.101051_bib34","series-title":"Developmental Biology","author":"Gilbert","year":"2000"},{"issue":"6","key":"10.1016\/j.modpat.2026.101051_bib35","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1158\/0008-5472.CAN-24-1507","article-title":"Comparative single-cell transcriptomics of human neuroblastoma and preclinical models reveals conservation of an adrenergic cell state","volume":"85","author":"Embaie","year":"2025","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib36","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1038\/s41467-021-24870-7","article-title":"Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors","volume":"12","author":"Bedoya-Reina","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ana.24659","article-title":"The \u201cneuro\u201d of neuroblastoma: neuroblastoma as a neurodevelopmental disorder","volume":"80","author":"Ratner","year":"2016","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1102\/1470-7330.2005.0104","article-title":"Neuroblastoma in childhood: review and radiological findings","volume":"5","author":"Papaioannou","year":"2005","journal-title":"Cancer Imaging"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1148\/radiol.11101352","article-title":"Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project","volume":"261","author":"Brisse","year":"2011","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.modpat.2026.101051_bib40","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ccell.2021.04.009","article-title":"Evolutionary switch in expression of key markers between mouse and human leads to mis-assignment of cell types in developing adrenal medulla","volume":"39","author":"Kameneva","year":"2021","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.modpat.2026.101051_bib41","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41588-021-00806-1","article-title":"Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma","volume":"53","author":"Jansky","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.modpat.2026.101051_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.667067","article-title":"Multiplex immunofluorescence tyramide signal amplification for immune cell profiling of paraffin-embedded tumor tissues","volume":"8","author":"Hernandez","year":"2021","journal-title":"Front Mol Biosci"},{"issue":"2","key":"10.1016\/j.modpat.2026.101051_bib43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12022-018-9534-7","article-title":"Old, new, and emerging immunohistochemical markers in pheochromocytoma and paraganglioma","volume":"29","author":"Cheung","year":"2018","journal-title":"Endocr Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101051_bib44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/ERC-13-0494","article-title":"Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma","volume":"21","author":"Kimura","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10.1016\/j.modpat.2026.101051_bib45","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00428-019-02553-5","article-title":"COPPS, a composite score integrating pathological features, PS100 and SDHB losses, predicts the risk of metastasis and progression-free survival in pheochromocytomas\/paragangliomas","volume":"474","author":"Pierre","year":"2019","journal-title":"Virchows Archiv"},{"issue":"5","key":"10.1016\/j.modpat.2026.101051_bib46","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101051_bib47","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.MP.0000056982.07160.E3","article-title":"KI-67 and hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma","volume":"16","author":"Elder","year":"2003","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2026.101051_bib48","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/modpathol.3800160","article-title":"CGH and CD 44\/MIB-1 immunohistochemistry are helpful to distinguish metastasized from nonmetastasized sporadic pheochromocytomas","volume":"17","author":"August","year":"2004","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101051_bib49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12022-020-09618-1","article-title":"The diagnostic dilemma of GATA3 immunohistochemistry in pheochromocytoma and paraganglioma","volume":"31","author":"Kimura","year":"2020","journal-title":"Endocr Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101051_bib50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/(SICI)1096-9896(200006)191:2<175::AID-PATH615>3.0.CO;2-Z","article-title":"Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases?","volume":"191","author":"Van Der Harst","year":"2000","journal-title":"J Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101051_bib51","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0046-8177(98)90070-3","article-title":"Prognostic markers in pheochromocytoma","volume":"29","author":"Clarke","year":"1998","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101051_bib53","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12022-018-9527-6","article-title":"Immunohistochemistry in diagnostic parathyroid pathology","volume":"29","author":"Erickson","year":"2018","journal-title":"Endocr Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101051_bib54","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12022-020-09615-4","article-title":"Utility of GATA-3 expression in the analysis of pituitary neuroendocrine tumour (PitNET) transcription factors","volume":"31","author":"Turchini","year":"2020","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101051_bib55","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41379-018-0167-7","article-title":"GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors","volume":"32","author":"Mete","year":"2019","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101051_bib56","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12022-020-09655-w","article-title":"Dopamine \u03b2-hydroxylase: an essential and optimal immunohistochemical marker for pheochromocytoma and sympathetic paraganglioma","volume":"32","author":"Kimura","year":"2021","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib57","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41467-023-36769-6","article-title":"Genomic and immune landscape of metastatic pheochromocytoma and paraganglioma","volume":"14","author":"Calsina","year":"2023","journal-title":"Nat Commun"},{"issue":"25","key":"10.1016\/j.modpat.2026.101051_bib58","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1056\/NEJMc1713444","article-title":"Tumor mutational burden and response rate to PD-1 inhibition","volume":"377","author":"Yarchoan","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib59","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med"},{"issue":"5","key":"10.1016\/j.modpat.2026.101051_bib60","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv053","article-title":"Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene","volume":"107","author":"Casc\u00f3n","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"38","key":"10.1016\/j.modpat.2026.101051_bib61","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1038\/onc.2008.228","article-title":"Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways","volume":"27","author":"McElhinny","year":"2008","journal-title":"Oncogene"},{"issue":"23","key":"10.1016\/j.modpat.2026.101051_bib62","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1242\/dev.062802","article-title":"Mastermind-like 1 (MamL1) and mastermind-like 3 (MamL3) are essential for Notch signaling in vivo","volume":"138","author":"Oyama","year":"2011","journal-title":"Development"},{"issue":"4","key":"10.1016\/j.modpat.2026.101051_bib63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12022-024-09830-3","article-title":"The molecular cassification of pheochromocytomas and paragangliomas: discovering the genomic and immune landscape of metastatic disease","volume":"35","author":"de Bresser","year":"2024","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib64","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12105-017-0786-1","article-title":"Update from the 4th Edition of the World Health Organization classification of head and neck tumours: paragangliomas","volume":"11","author":"Williams","year":"2017","journal-title":"Head Neck Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101051_bib65","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3390\/cancers11050724","article-title":"Malignant pheochromocytomas\/paragangliomas and ectopic hormonal secretion: a case series and review of the literature","volume":"11","author":"Angelousi","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.modpat.2026.101051_bib66","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1210\/jc.2006-1544","article-title":"Clinical review: current treatment of malignant pheochromocytoma","volume":"92","author":"Scholz","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.modpat.2026.101051_bib67","first-page":"1160","article-title":"Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features","volume":"21","author":"Linnoila","year":"1990","journal-title":"Hum Pathol"},{"issue":"10","key":"10.1016\/j.modpat.2026.101051_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223827","article-title":"Clonality analysis of pulmonary tumors by genome-wide copy number profiling","volume":"14","author":"Vincenten","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.modpat.2026.101051_bib69","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1210\/jc.2018-01968","article-title":"Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-Prono study): a European network for the study of adrenal tumors retrospecitve study","volume":"104","author":"Hescot","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib70","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1038\/ncomms7044","article-title":"Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas","volume":"6","author":"Castro-Vega","year":"2015","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.modpat.2026.101051_bib71","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.modpat.2026.101051_bib72","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/er.2017-00062","article-title":"New perspectives on pheochromocytoma and paraganglioma: towards a molecular classification","volume":"38","author":"Crona","year":"2017","journal-title":"Endocr Rev"},{"issue":"8","key":"10.1016\/j.modpat.2026.101051_bib73","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00432-017-2397-3","article-title":"SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations","volume":"143","author":"Jochmanova","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.modpat.2026.101051_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.672531","article-title":"Tissue multiplex analyte detection in anatomic pathology - pathways to clinical implementation","volume":"8","author":"Wharton","year":"2021","journal-title":"Front Mol Biosci"},{"issue":"8","key":"10.1016\/j.modpat.2026.101051_bib75","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/jamaoncol.2019.1549","article-title":"Comparison of biomarker modalities for predicting response to PD-1\/PD-L1 checkpoint blockade: a systematic review and meta-analysis","volume":"5","author":"Lu","year":"2019","journal-title":"JAMA Oncol"},{"issue":"10135","key":"10.1016\/j.modpat.2026.101051_bib76","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pag\u00e8s","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.modpat.2026.101051_bib77","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.modpat.2026.101051_bib78","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/endrev\/bnae005","article-title":"The immune landscape of pheochromocytoma and paraganglioma: current advances and perspectives","volume":"45","author":"Uher","year":"2024","journal-title":"Endocr Rev"},{"issue":"7637","key":"10.1016\/j.modpat.2026.101051_bib79","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.modpat.2026.101051_bib80","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib82","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1038\/s41467-022-34011-3","article-title":"Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment","volume":"13","author":"Zethoven","year":"2022","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.modpat.2026.101051_bib81","doi-asserted-by":"crossref","first-page":"R239","DOI":"10.1530\/ERC-20-0043","article-title":"Antiangiogenic therapies for pheochromocytoma and paraganglioma","volume":"127","author":"Jimenez","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.modpat.2026.101051_bib83","article-title":"Transcriptional subtypes on immune microenvironment and predicting postoperative recurrence and metastasis in pheochromocytoma and paraganglioma","volume":"14","author":"Liu","year":"2025","journal-title":"Cancer Biol"},{"issue":"22","key":"10.1016\/j.modpat.2026.101051_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212608","article-title":"Hypoxia: the cornerstone of glioblastoma","volume":"22","author":"Dom\u00e8nech","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"23","key":"10.1016\/j.modpat.2026.101051_bib85","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N Engl J Med"},{"issue":"6230","key":"10.1016\/j.modpat.2026.101051_bib86","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non\u2013small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"issue":"26","key":"10.1016\/j.modpat.2026.101051_bib87","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.modpat.2026.101051_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1022131","article-title":"Initial characterization of immune microenvironment in pheochromocytoma and paraganglioma","volume":"13","author":"Jin","year":"2022","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib89","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/imr.12766","article-title":"Immune checkpoint inhibitors: the linchpins of modern immunotherapy","volume":"290","author":"Wilky","year":"2019","journal-title":"Immunol Rev"},{"issue":"26","key":"10.1016\/j.modpat.2026.101051_bib90","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti\u2013PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Eng J Med"},{"key":"10.1016\/j.modpat.2026.101051_bib91","doi-asserted-by":"crossref","unstructured":"Doroshow DB, Bhalla S, Beasley MB, et al. PD-L1 as a biomarker of response to immune-checkpoint inhibitors. Nat Rev Clin Oncol. 18(6):345-362. https:\/\/doi.org\/10.1038\/s41571-021-00473-5.","DOI":"10.1038\/s41571-021-00473-5"},{"issue":"9","key":"10.1016\/j.modpat.2026.101051_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2023.100210","article-title":"PD-L1 expression is linked to tumor-infiltrating T-cell exhaustion and adverse pathological behavior in pheochromocytoma\/paraganglioma","volume":"103","author":"Yu","year":"2023","journal-title":"Lab Invest"},{"key":"10.1016\/j.modpat.2026.101051_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1212476","article-title":"Cancer immunotherapies: advances and bottlenecks","volume":"14","author":"Rui","year":"2023","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101051_bib94","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.2535","article-title":"Estimation of the percentage of US patients with cancer who are eigible for and respond to checkpoint inhibitor immunotherapy drugs","volume":"2","author":"Haslam","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib95","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","article-title":"Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance","volume":"16","author":"Bagchi","year":"2021","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib96","first-page":"147","article-title":"Mechanism underlying the immune checkpoint inhibitor-induced hyper-progressive state of cancer","volume":"5","author":"Ding","year":"2022","journal-title":"Cancer Drug Resist"},{"issue":"8","key":"10.1016\/j.modpat.2026.101051_bib97","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1158\/1078-0432.CCR-16-1741","article-title":"Hyperprogressive disease is a new pattern of progression in cancer patients treated by anti-PD-1\/PD-L1","volume":"23","author":"Champiat","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.modpat.2026.101051_bib98","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/cac2.12023","article-title":"Overview of multiplex immunohistochemistry\/immunofluorescence techniques in the era of cancer immunotherapy","volume":"40","author":"Tan","year":"2020","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib99","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008875","article-title":"Society for immunotherapy ofcancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing","volume":"13","author":"Taube","year":"2025","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib100","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1155","article-title":"Multiplex immunofluorescence and single-cell transcriptomic profiling reveal the spatial cell interaction networks in the non-small cell lung cancer microenvironment","volume":"13","author":"Peng","year":"2023","journal-title":"Clin Transl Med"},{"issue":"12","key":"10.1016\/j.modpat.2026.101051_bib101","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1515","article-title":"Single-cell and spatial transcriptomics reveal POSTN+ cancer-associated fibroblasts correlated with immune suppression and tumour progression in non-small cell lung cancer","volume":"13","author":"Chen","year":"2023","journal-title":"Clin Transl Med"},{"issue":"5","key":"10.1016\/j.modpat.2026.101051_bib102","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/14737159.2020.1743178","article-title":"Advances in quantitative immunohistochemistry and their contribution to breast cancer","volume":"20","author":"Yaghoobi","year":"2020","journal-title":"Expert Rev Mol Diagn"},{"issue":"2","key":"10.1016\/j.modpat.2026.101051_bib103","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/his.14328","article-title":"Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry\/immunofluorescence","volume":"79","author":"Tien","year":"2021","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib104","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1038\/s41467-022-32570-z","article-title":"Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12967-025-06376-8","article-title":"Single-cell RNA sequencing and spatial transcriptomics reveal the heterogeneity and intercellular communication of cancer-associated fibroblasts in gastric cancer","volume":"23","author":"Zhang","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.modpat.2026.101051_bib106","series-title":"Basic Cell Culture","author":"McAteer","year":"2002"},{"issue":"12","key":"10.1016\/j.modpat.2026.101051_bib108","doi-asserted-by":"crossref","first-page":"R433","DOI":"10.1530\/ERC-19-0434","article-title":"Advances in paraganglioma-pheochromocytoma cell lines and xenografts","volume":"27","author":"Bayley","year":"2020","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"10.1016\/j.modpat.2026.101051_bib109","first-page":"337","article-title":"Carotid body tumor in tissue culture","volume":"40","author":"Costero","year":"1962","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101051_bib110","first-page":"257","article-title":"Tissue culture, electron microscopic and enzyme histochemical investigations of extraadrenal paragangliomas","volume":"11","author":"Gullotta","year":"1976","journal-title":"Pathol Eur"},{"issue":"3","key":"10.1016\/j.modpat.2026.101051_bib111","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF00209993","article-title":"Spontaneous neurite outgrowth and vasoactive intestinal peptide-like immunoreactivity of cultures of human paraganglioma cells from the glomus jugulare","volume":"219","author":"Tischler","year":"1981","journal-title":"Cell Tissue Res"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0360-3016(92)90545-S","article-title":"Radiosensitivity, repair capacity, and stem cell fraction in human soft tissue tumors: an in vitro study using multicellular spheroids and the colony assay","volume":"23","author":"Stuschke","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.modpat.2026.101051_bib114","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0360-3016(93)90347-X","article-title":"The TCD50 and regrowth delay assay in human tumor xenografts: differences and implications","volume":"25","author":"Budach","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.modpat.2026.101051_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178995","article-title":"Effects of PPAR\u03b1 inhibition in head and neck paraganglioma cells","volume":"12","author":"Florio","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.modpat.2026.101051_bib117","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00401-013-1165-y","article-title":"Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling","volume":"126","author":"Cama","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101051_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065624","article-title":"Progenitor cell line (hPheo1) derived from a human pheochromocytoma tumor","volume":"8","author":"Ghayee","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.modpat.2026.101051_bib119","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/1097-0142(197202)29:2<327::AID-CNCR2820290210>3.0.CO;2-3","article-title":"Pheochromocytoma","volume":"29","author":"Warren","year":"1972","journal-title":"Cancer"},{"issue":"42","key":"10.1016\/j.modpat.2026.101051_bib120","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.modpat.2026.101051_bib121","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/10408440903190861","article-title":"Chemically induced pheochromocytomas in rats: mechanisms and relevance for human risk assessment","volume":"39","author":"Greim","year":"2009","journal-title":"Crit Rev Toxicol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib122","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/1097-0142(197307)32:1<227::AID-CNCR2820320134>3.0.CO;2-W","article-title":"Ultrastructure and in vitro growth characteristics of a transplantable rat pheochromocytoma","volume":"31","author":"DeLellis","year":"1973","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.modpat.2026.101051_bib123","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1530\/ERC-19-0474","article-title":"A xenograft and cell line model of SDH-deficient pheochromocytoma derived from Sdhb+\/- rats","volume":"27","author":"Powers","year":"2020","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.modpat.2026.101051_bib124","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/path.1711280208","article-title":"Aortic body tumours and hyperplasia in the rat","volume":"128","author":"Van Zwieten","year":"1979","journal-title":"J Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101051_bib125","first-page":"736","article-title":"Cytomorphological description of an abdominal extra-adrenal paraganglioma in a Fischer 344 rat","volume":"38","author":"Pirak","year":"1988","journal-title":"Lab Anim Sci"},{"issue":"5","key":"10.1016\/j.modpat.2026.101051_bib126","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.etp.2012.07.002","article-title":"A paraganglioma in the posterior wall of the left atrium originating from the aortic body in a Wistar Hannover rat","volume":"65","author":"Li","year":"2013","journal-title":"Exp Toxicol Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101051_bib127","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/030098588702400405","article-title":"Pathologic features of abdominal and thoracic paragangliomas in F344\/N rats","volume":"24","author":"Hall","year":"1987","journal-title":"Vet Pathol"},{"issue":"7","key":"10.1016\/j.modpat.2026.101051_bib128","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1073\/pnas.73.7.2424","article-title":"Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor","volume":"73","author":"Greene","year":"1976","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.modpat.2026.101051_bib129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/B978-0-12-028608-9.50006-5","article-title":"The migration and differentiation of neural crest cells","volume":"8","author":"Weston","year":"1970","journal-title":"Adv Morphog"},{"issue":"3","key":"10.1016\/j.modpat.2026.101051_bib130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s004410000290","article-title":"Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice","volume":"302","author":"Powers","year":"2000","journal-title":"Cell Tissue Res"},{"issue":"4","key":"10.1016\/j.modpat.2026.101051_bib131","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF02738732","article-title":"Characterization of pheochromocytomas in a mouse strain with a targeted disruptive mutation of the neurofibromatosis gene Nf1","volume":"6","author":"Tischler","year":"1995","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101051_bib132","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/mc.20388","article-title":"Metastasis-associated gene expression profile of liver and subcutaneous lesions derived from mouse pheochromocytoma cells","volume":"47","author":"Ohta","year":"2008","journal-title":"Mol Carcinog"},{"issue":"3","key":"10.1016\/j.modpat.2026.101051_bib133","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10585-009-9236-0","article-title":"Characterization of an animal model of aggressive metastatic pheochromocytoma linked to a specific gene signature","volume":"26","author":"Martiniova","year":"2009","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib134","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/cge.13055","article-title":"The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers","volume":"93","author":"Rijken","year":"2018","journal-title":"Clin Genet"},{"issue":"5","key":"10.1016\/j.modpat.2026.101051_bib135","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1530\/ERC-19-0024","article-title":"Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis","volume":"26","author":"Crona","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"10.1016\/j.modpat.2026.101051_bib112","first-page":"2672","article-title":"In vitro propagation of human ocular surface epithelial cells for transplantation","volume":"34","author":"Lindberg","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.modpat.2026.101051_bib113","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM198408163110706","article-title":"Permanent coverage of large burn wounds with autologous cultured human epithelium","volume":"311","author":"Gallico","year":"1984","journal-title":"N Engl J Med"},{"issue":"8211","key":"10.1016\/j.modpat.2026.101051_bib136","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(81)90006-4","article-title":"Grafting of burns with cultured epithelium prepared from autologous epidermal cells","volume":"317","author":"O\u2019Connor","year":"1981","journal-title":"Lancet"},{"issue":"9057","key":"10.1016\/j.modpat.2026.101051_bib137","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0140-6736(96)11188-0","article-title":"Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium","volume":"349","author":"Pellegrini","year":"1997","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.modpat.2026.101051_bib138","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMoa0905955","article-title":"Limbal stem-cell therapy and long-term corneal regeneration","volume":"363","author":"Rama","year":"2010","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.modpat.2026.101051_bib139","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling development and disease with organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.modpat.2026.101051_bib140","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"10.1016\/j.modpat.2026.101051_bib141","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/ng.3967","article-title":"Patient-derived xenografts undergo mouse-specific tumor evolution","volume":"49","author":"Ben-David","year":"2017","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.modpat.2026.101051_bib142","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nrc.2016.140","article-title":"Interrogating open issues in cancer precision medicine with patient-derived xenografts","volume":"17","author":"Byrne","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"10.1016\/j.modpat.2026.101051_bib143","first-page":"3669","article-title":"The antiangiogenic agent linomide inhibits the growth rate of von Hippel-Lindau paraganglioma xenografts to mice","volume":"5","author":"Gross","year":"1999","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib144","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12022-016-9452-5","article-title":"Pathology of human pheochromocytoma and paraganglioma xenografts in NSG mice","volume":"28","author":"Powers","year":"2017","journal-title":"Endocr Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101051_bib145","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00401-017-1799-2","article-title":"Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib","volume":"135","author":"Verginelli","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib146","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.gde.2013.11.012","article-title":"Organoid cultures for the analysis of cancer phenotypes","volume":"24","author":"Sachs","year":"2014","journal-title":"Curr Opin Genet Dev"},{"issue":"7244","key":"10.1016\/j.modpat.2026.101051_bib147","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.modpat.2026.101051_bib148","doi-asserted-by":"crossref","first-page":"IE.9.1","DOI":"10.1002\/cpsc.1","article-title":"Production of 3-D airway organoids from primary human airway basal cells and their use in high-throughput screening","volume":"37","author":"Hild","year":"2016","journal-title":"Curr Protoc Stem Cell Biol"},{"key":"10.1016\/j.modpat.2026.101051_bib149","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.biomaterials.2016.10.046","article-title":"Human airway organoid engineering as a step toward lung regeneration and disease modeling","volume":"113","author":"Tan","year":"2017","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.modpat.2026.101051_bib150","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100300","article-title":"Long-term expanding human airway organoids for disease modeling","volume":"38","author":"Sachs","year":"2019","journal-title":"EMBO J"},{"issue":"5","key":"10.1016\/j.modpat.2026.101051_bib151","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","article-title":"Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett\u2019s epithelium","volume":"141","author":"Sato","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib152","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/j.gastro.2014.09.042","article-title":"In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection","volume":"148","author":"Bartfeld","year":"2015","journal-title":"Gastroenterology"},{"issue":"1-2","key":"10.1016\/j.modpat.2026.101051_bib153","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","article-title":"Long-term culture of genome-stable bipotent stem cells from adult human liver","volume":"160","author":"Huch","year":"2015","journal-title":"Cell"},{"issue":"1-2","key":"10.1016\/j.modpat.2026.101051_bib154","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","article-title":"Organoid models of human and mouse ductal pancreatic cancer","volume":"160","author":"Boj","year":"2015","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.modpat.2026.101051_bib155","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/ncb3047","article-title":"Single luminal epithelial progenitors can generate prostate organoids in culture","volume":"16","author":"Chua","year":"2014","journal-title":"Nat Cell Biol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101051_bib156","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41587-019-0048-8","article-title":"Tubuloids derived from human adult kidney and urine for personalized disease modeling","volume":"37","author":"Schutgens","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"10","key":"10.1016\/j.modpat.2026.101051_bib157","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206447","article-title":"Tubular organotypic culture model of human kidney","volume":"13","author":"Jun","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib158","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1038\/ncomms9989","article-title":"The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids","volume":"6","author":"Kessler","year":"2015","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.modpat.2026.101051_bib159","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1073\/pnas.1803595116","article-title":"Mouse and human urothelial cancer organoids: a tool for bladder cancer research","volume":"116","author":"Mullenders","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.modpat.2026.101051_bib160","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","article-title":"Tumor evolution and drug response in patient-derived organoid models of bladder cancer","volume":"173","author":"Lee","year":"2018","journal-title":"Cell"},{"issue":"1-2","key":"10.1016\/j.modpat.2026.101051_bib161","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","article-title":"A living biobank of breast cancer organoids captures disease heterogeneity","volume":"172","author":"Sachs","year":"2018","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.modpat.2026.101051_bib162","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective derivation of a living organoid biobank of colorectal cancer patients","volume":"161","author":"Van de Wetering","year":"2015","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.modpat.2026.101051_bib163","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.cell.2018.07.027","article-title":"Divergent routes toward Wnt and R-spondin niche independency during human gastric carcinogenesis","volume":"174","author":"Nanki","year":"2018","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.modpat.2026.101051_bib164","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.stem.2018.09.016","article-title":"A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening","volume":"23","author":"Yan","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.modpat.2026.101051_bib165","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121490","article-title":"Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity","volume":"4","author":"Li","year":"2019","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.modpat.2026.101051_bib166","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer-derived organoid cultures for disease modeling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.modpat.2026.101051_bib167","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/nm.3973","article-title":"Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids","volume":"21","author":"Huang","year":"2015","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib168","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","article-title":"Organoid cultures derived from patients with advanced prostate cancer","volume":"159","author":"Gao","year":"2014","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.modpat.2026.101051_bib169","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nprot.2016.006","article-title":"Organoid culture systems for prostate epithelial and cancer tissue","volume":"11","author":"Drost","year":"2016","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib170","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1038\/s41467-018-05190-9","article-title":"Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics","volume":"9","author":"Li","year":"2018","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.modpat.2026.101051_bib171","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","article-title":"An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity","volume":"25","author":"Kopper","year":"2019","journal-title":"Nat Med"},{"issue":"7702","key":"10.1016\/j.modpat.2026.101051_bib172","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-018-0024-3","article-title":"Intra-tumour diversification in colorectal cancer at the single-cell level","volume":"556","author":"Roerink","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.modpat.2026.101051_bib173","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.stem.2017.12.009","article-title":"Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression","volume":"22","author":"Seino","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib174","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14262","article-title":"Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors","volume":"8","author":"Sch\u00fctte","year":"2017","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.modpat.2026.101051_bib175","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.stem.2016.04.003","article-title":"A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis","volume":"18","author":"Fujii","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"15","key":"10.1016\/j.modpat.2026.101051_bib176","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019101654","article-title":"Xenograft and organoid model systems in cancer research","volume":"38","author":"Bleijs","year":"2019","journal-title":"EMBO J"},{"issue":"9","key":"10.1016\/j.modpat.2026.101051_bib177","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaf114","article-title":"Canine adrenomedullary and pheochromocytoma organoids: a novel in vitro model","volume":"166","author":"Van Den Berg","year":"2025","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.modpat.2026.101051_bib178","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/vco.12291","article-title":"Pheochromocytomas and paragangliomas in humans and dogs","volume":"15","author":"Galac","year":"2017","journal-title":"Vet Comp Oncol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101051_bib179","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3390\/cancers11050607","article-title":"Molecular alterations in dog pheochromocytomas and paragangliomas","volume":"11","author":"Korpershoek","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcpa.2014.03.007","article-title":"Succinate dehydrogenase subunit D and succinate dehydrogenase subunit B mutation analysis in canine phaeochromocytoma and paraganglioma","volume":"151","author":"Holt","year":"2014","journal-title":"J Comp Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib181","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-19806-w","article-title":"Biofabrication of pheochromocytoma and paraganglioma tumor organoids and assessment of response to systemic therapy","volume":"15","author":"Erali","year":"2025","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.modpat.2026.101051_bib182","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/MPA.0000000000001792","article-title":"The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and\/or Unresectable Pheochromocytoma and Paraganglioma","volume":"50","author":"Fishbein","year":"2021","journal-title":"Pancreas"},{"issue":"5","key":"10.1016\/j.modpat.2026.101051_bib183","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/cen.12542","article-title":"Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis","volume":"81","author":"Niemeijer","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib184","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12943-025-02477-6","article-title":"Turning cold tumors into hot tumors to ignite immunotherapy","volume":"24","author":"Liu","year":"2025","journal-title":"Mol Cancer"},{"key":"10.1016\/j.modpat.2026.101051_bib185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1487296","article-title":"From cold to hot: mechanisms of hyperthermia in modulating tumor immunology for enhanced immunotherapy","volume":"16","author":"Abreu","year":"2025","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101051_bib186","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1038\/s41467-023-39759-w","article-title":"Interventional hydrogel microsphere vaccine as an immune amplifier for activated antitumour immunity after ablation therapy","volume":"14","author":"Liu","year":"2023","journal-title":"Nat Commun"},{"issue":"6378","key":"10.1016\/j.modpat.2026.101051_bib187","first-page":"920","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science (1979)"},{"issue":"9","key":"10.1016\/j.modpat.2026.101051_bib188","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.chembiol.2017.06.012","article-title":"Tumor organoids as a pre-clinical cancer model for drug discovery","volume":"24","author":"Weeber","year":"2017","journal-title":"Cell Chem Biol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101051_bib189","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1158\/2159-8290.CD-12-0012","article-title":"Circumventing cancer drug resistance in the era of personalized medicine","volume":"2","author":"Garraway","year":"2012","journal-title":"Cancer Discov"},{"issue":"10","key":"10.1016\/j.modpat.2026.101051_bib190","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat Rev Cancer"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:29:27Z","timestamp":1792582167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226000943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":189,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0893395226000943"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101051","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paragangliomas and Pheochromocytomas: Integrating Developmental Biology With Translational Technologies. A Narrative Review","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"101051"}}